MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ric.2025.100022

Медицинская библиотека · Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion · 2025

Geniposide reverses oxaliplatin resistance in colorectal cancer via suppression of PI3K/AKT pathway.

Chen Siyuan, Chen Aijun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

As a first-line chemotherapy agent for colorectal cancer (CRC), oxaliplatin suffers from limited efficacy due to acquired resistance. This study investigated whether geniposide can overcome oxaliplatin resistance in preclinical models and elucidated the underlying molecular mechanisms.

METHODS

We employed MTT, colony formation, flow cytometry, wound healing, and Transwell assays to evaluate viability, proliferation, apoptosis, migration, and invasion in oxaliplatin-resistant CRC cells (SW480/R, LoVo/R) treated with geniposide and/or oxaliplatin. Xenograft models bearing SW480/R or LoVo/R tumors were established to assess in vivo efficacy. Immunofluorescence analysis quantified Ki67-positive proliferating cells, while Western blot measured apoptosis markers (Bax, Bcl-2) and PI3K/AKT/mTOR pathway activity.

RESULTS

Geniposide-oxaliplatin combination therapy significantly inhibited proliferation, migration, and invasion while inducing apoptosis in resistant CRC cells beyond monotherapy effects. In vivo, geniposide restored oxaliplatin sensitivity, substantially reducing tumor growth and Ki67 proliferation index. Mechanistically, geniposide suppressed phosphorylation of AKT and mTOR in both cellular and xenograft models, with maximal inhibition observed in combination groups.

CONCLUSION

Geniposide reverses oxaliplatin resistance in CRC through PI3K/AKT pathway inhibition, demonstrating that geniposide-oxaliplatin combination therapy represents a promising therapeutic strategy for oxaliplatin-resistant CRC. .

Для цитирования: Chen Siyuan, Chen Aijun. Geniposide reverses oxaliplatin resistance in colorectal cancer via suppression of PI3K/AKT pathway.. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 2025. DOI: 10.1016/j.ric.2025.100022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.